Results 211 to 220 of about 174,743 (266)

Association of MMP-9 and TIMP-1 concentration with neurological outcome after cardiac arrest and resuscitation - a substudy of the COMACARE trial. [PDF]

Resusc Plus
Kortesuo E, Tirkkonen J, Reinikainen M, Pekkarinen PT, Moilanen E, Petäjä L, Skrifvars MB, Hästbacka J.   +7 more
europepmc   +1 more source

Tissue inhibitor of metalloproteinase-1 [PDF]

Springer Reference Medizin, 2019
S. Holdenrieder, P. Stieber
semanticscholar   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Usefulness of metalloproteinase‐9 and tissue inhibitor of metalloproteinase‐1 in clinical characterisation of children with newly diagnosed Crohn's disease

Journal of Paediatrics and Child Health, 2020
The aim of this study was to determine the relation of non‐invasive markers representing gut mucosal damage (metalloproteinase‐9 (MMP‐9)) and remodelling (tissue inhibitor of metalloproteinase‐1 (TIMP‐1)) with Crohn's disease (CD) phenotype, disease ...
U. Daniluk, J. Daniluk, K. Guzińska-ustyMowiCz, A. Pryczynicz, D. Lebensztejn   +4 more
semanticscholar   +1 more source

Tissue inhibitor of metalloproteinases-1 in breast cancer

Endocrine Related Cancer, 2005
Whether patients diagnosed with primary breast cancer are offered adjuvant systemic therapy following surgical removal of the tumor is based on prognosis. Prognosis is estimated in every patient using established prognostic variables. Unfortunately, when using the currently available prognostic parameters a significant proportion of patients are over ...
Würtz, Sidse Ørnbjerg, Rasmussen, Anne-Sofie Schrohl, Sørensen, Nanna Møller, Lademann, Ulrik, Christensen, Ib Jarle, Mouridsen, H., Brünner, Nils   +6 more
openaire   +3 more sources

Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer

International Journal of Cancer, 1997
We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these proteins in healthy male controls (n = 35), and in ...
K, Jung, L, Nowak, M, Lein, F, Priem, D, Schnorr, S A, Loening   +5 more
openaire   +2 more sources

Effect of psoriasis treatment on plasma concentrations of metalloproteinase‐1 and tissue inhibitor of metalloproteinases‐1

Journal of the European Academy of Dermatology and Venereology, 2005
ABSTRACTAim  The aim of this study was to evaluate the effect of psoriasis treatment on plasma concentrations of metalloproteinase‐1 (MMP‐1) and tissue inhibitor of metalloproteinases‐1 (TIMP‐1) with respect to disease severity.Methods  MMP‐1 and TIMP‐1 were measured using an enzyme immunoassay in plasma of 32 patients before and after topical ...
I, Flisiak, H, Myśliwiec, B, Chodynicka
openaire   +3 more sources

Neuroprotection from Tissue Inhibitor of Metalloproteinase-1 and its nanoparticles

Neurochemistry International, 2012
Matrix metalloproteinases (MMPs) are family of zinc dependent endopeptidases, which cleave extracellular matrix proteins, and play an important role in tissue remodelling in physiological and pathological processes. There is enhanced expression of MMPs, in particular MMP-9, during numerous pathological conditions, including epilepsy and ischemic stroke.
Chaturvedi, Mayank, Figiel, Izabela, Sreedhar, Bojja, Kaczmarek, Leszek   +3 more
openaire   +2 more sources

Sp1‐dependent regulation of the tissue inhibitor of metalloproteinases‐1 promoter

Journal of Cellular Biochemistry, 2004
AbstractExtracellular matrix (ECM) remodeling is involved in many cellular properties such as division, migration, differentiation, and death. The turnover of ECM is regulated by matrix metalloproteinases (MMPs) and the MMPs are inhibited by the tissue inhibitors of metalloproteinases (TIMPs). In this study, the transcriptional regulation of the TIMP‐1
Minhyung, Lee, Sun U, Song, Ji Kan, Ryu, Jun Kyu, Suh   +3 more
openaire   +2 more sources

Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components

Scandinavian Journal of Clinical and Laboratory Investigation, 2002
Blood transfusion during surgery for solid tumors may reduce patient survival because of various bioactive substances present in blood preparations. The anti-proteolytic protein tissue inhibitor of metalloproteinases-1 (TIMP-1) present in large quantities in platelets has been shown to stimulate cell growth and to inhibit apoptosis and may therefore be
M N, Holten-Andersen, N, Brunner, I J, Christensen, V, Jensen, H J, Nielsen   +4 more
openaire   +2 more sources